Haemonetics Corporation
HAE | NYSE
$120.91
+$1.26 (+1.05%)
Nov 2, 2026, 12:01 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 28, 2026 | FY 2025 Mar 29, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | 26.36 | 19.09 | 36.55 | 36.45 | 74.38 | 70.71 |
PEG Ratio | -0.69 | 0.45 | 16.59 | 0.22 | -1.62 | 17.79 |
PS Ratio | 1.91 | 2.34 | 3.28 | 3.60 | 3.25 | 6.46 |
PB Ratio | 3.20 | 3.87 | 4.48 | 5.14 | 4.31 | 7.69 |
P/FCF Ratio | 9.79 | 22.33 | 29.93 | 25.80 | 42.60 | 78.41 |
P/OCF Ratio | 8.69 | 17.50 | 23.66 | 15.39 | 18.73 | 51.72 |
OCF/S Ratio | 21.98 | 13.35 | 13.88 | 23.37 | 17.34 | 12.50 |
Debt / Equity Ratio | 1.54 | 1.49 | 0.84 | 0.94 | 1.04 | 1.06 |
Quick Ratio | 1.87 | 0.99 | 1.50 | 2.03 | 1.05 | 1.46 |
Current Ratio | 2.95 | 1.62 | 2.56 | 3.06 | 1.71 | 2.74 |
Asset Turnover | 0.56 | 0.56 | 0.60 | 0.60 | 0.53 | 0.48 |
Interest Coverage | 8.41 | 22.76 | 12.67 | 10.67 | 4.72 | 5.33 |
Return on Equity | 12.22% | 20.43% | 12.25% | 14.11% | 5.79% | 10.86% |
Return on Assets | 4.06% | 6.84% | 5.35% | 5.96% | 2.33% | 4.37% |
Return on Invested Capital | 8.66% | 8.06% | 6.70% | 7.51% | 3.36% | 5.64% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 55.74% | 57.21% | 54.38% | 53.30% | 53.44% | 49.22% |
Net Profit Margin | 7.29% | 12.32% | 8.98% | 9.87% | 4.37% | 9.13% |
Pretax Profit Margin | 9.60% | 15.58% | 11.60% | 12.10% | 6.41% | 8.38% |
Operating Profit Margin | 18.10% | 16.30% | 12.60% | 13.35% | 8.13% | 10.31% |
FCF Margin | 19.52% | 10.47% | 10.97% | 13.94% | 7.63% | 8.24% |
EBITDA Margin | 23.42% | 26.16% | 22.57% | 21.56% | 19.30% | 21.18% |
Add to Watchlist
Select watchlists to add or remove HAE